These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4813331)

  • 1. Hyperdynamic states and the physiologic determinants of survival in patients with cirrhosis and portal hypertension.
    Siegel JH; Goldwyn RM; Farrell EJ; Gallin P; Friedman HP
    Arch Surg; 1974 Mar; 108(3):282-92. PubMed ID: 4813331
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiorespiratory interactions as determinants of survival and the need for respiratory support in human shock states.
    Siegel JH; Farrell EJ; Miller M; Goldwyn RM; Friedman HP
    J Trauma; 1973 Jul; 13(7):602-19. PubMed ID: 4715029
    [No Abstract]   [Full Text] [Related]  

  • 3. A computer based index for the prediction of operative survival in patients with cirrhosis and portal hypertension.
    Siegel JH; Williams JB
    Ann Surg; 1969 Feb; 169(2):191-201. PubMed ID: 5764206
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical implications of the hyperdynamic syndrome in cirrhosis.
    Licata A; Mazzola A; Ingrassia D; Calvaruso V; Cammà C; Craxì A
    Eur J Intern Med; 2014 Nov; 25(9):795-802. PubMed ID: 25245607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic patterns in surviving and nonsurviving shock patients. Use of sequential cardiorespiratory variables in defining criteria for therapeutic goals and early warning of death.
    Shoemaker WC; Montgomery ES; Kaplan E; Elwyn DH
    Arch Surg; 1973 May; 106(5):630-6. PubMed ID: 4701410
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension.
    Møller S; Krag A; Madsen JL; Henriksen JH; Bendtsen F
    Liver Int; 2009 Nov; 29(10):1528-37. PubMed ID: 19725890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic and functional aspects of portal hypertension decompensation in liver cirrhosis].
    Kalita NIa; Kotenko OG; Bulanov KI; Furmanenko ED; Egorova OE
    Klin Khir (1962); 1994; (11):37-41. PubMed ID: 7658658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood gases and acid-base disturbances of arterial blood in chronic liver disease.
    Kardel T; Rasmussen SN
    Scand J Clin Lab Invest; 1973 May; 31(3):307-9. PubMed ID: 4755035
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension.
    Rabol A; Juhl E; Schmidt A; Winkler K
    Digestion; 1976; 14(3):285-9. PubMed ID: 955334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
    Møller S; Henriksen JH; Bendtsen F
    World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of central venous pressure as a measure of changes in left sided intracardiac pressures.
    Hanashiro PK; Weil MH
    Chest; 1972 Oct; 62(4):479-83. PubMed ID: 5078004
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis again.
    Keiding S; Vilstrup H
    Scand J Gastroenterol; 2002 Nov; 37(11):1344. PubMed ID: 12465737
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disturbance of the acid-bace equilibrium in cirrhotics].
    Beraud C; Dangomau J; Bricaud H; Liermain A; Quinton A; Traissac FJ
    Rev Fr Etud Clin Biol; 1968 May; 13(5):484-96. PubMed ID: 5674735
    [No Abstract]   [Full Text] [Related]  

  • 14. [The blood circulation of the liver in cirrhosis with the portal hypertension syndrome].
    Kotenko OG
    Klin Khir; 1996; (11-12):17-21. PubMed ID: 9182005
    [No Abstract]   [Full Text] [Related]  

  • 15. Autonomic dysfunction in cirrhosis and portal hypertension.
    Dümcke CW; Møller S
    Scand J Clin Lab Invest; 2008; 68(6):437-47. PubMed ID: 18609092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Echographic and hemodynamic indicators in liver cirrhosis with portal hypertension].
    Rikhsieva LE; Akhmedzhanova ShSh; Miasnik BN
    Sov Med; 1989; (2):13-5. PubMed ID: 2658117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular spider: a cutaneous manifestation of hyperdynamic blood flow in hepatic cirrhosis.
    Witte CL; Hicks T; Renert W; Witte MH; Butler C
    South Med J; 1975 Feb; 68(2):246-8. PubMed ID: 235157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of irreversible hemorrhagic shock in monkeys.
    Rutherford RB; Trow RS
    J Surg Res; 1973 Jun; 14(6):538-50. PubMed ID: 4196706
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.